These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. McCullough PA; Kuncheria J; Mathur VS Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695 [TBL] [Abstract][Full Text] [Related]
9. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688 [TBL] [Abstract][Full Text] [Related]
10. Nesiritide for the treatment of decompensated heart failure. Colucci WS J Card Fail; 2001 Mar; 7(1):92-100. PubMed ID: 11264555 [TBL] [Abstract][Full Text] [Related]
11. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure. Aronson D; Burger AJ Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294 [TBL] [Abstract][Full Text] [Related]
12. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U; Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437 [TBL] [Abstract][Full Text] [Related]
13. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247 [TBL] [Abstract][Full Text] [Related]
14. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide. Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938 [TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633 [TBL] [Abstract][Full Text] [Related]
16. Nesiritide for the treatment of decompensated heart failure. Wylie JV; Tsao L Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426 [TBL] [Abstract][Full Text] [Related]
18. Critical review and recommendations for nesiritide use in the emergency department. Collins SP; Hinckley WR; Storrow AB J Emerg Med; 2005 Oct; 29(3):317-29. PubMed ID: 16183453 [TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effect of recombinant human brain natriuretic peptide for treatment of decompensated heart failure: comparison with nitroglycerin]. Xie CL; Meng SR; Wang W; Chen SM; Li P; Feng XG Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):839-42. PubMed ID: 18504215 [TBL] [Abstract][Full Text] [Related]
20. [The role of natriuretic peptides in heart failure]. Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; CalabrĂ² P; Di Salvo G; CalabrĂ² R Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]